Xie Y, Zhang S, Wu Y, Qi Y, Qi S, Chen X
Discov Oncol. 2025; 16(1):322.
PMID: 40088361
DOI: 10.1007/s12672-025-02078-1.
Fiorini E, Malinova A, Schreyer D, Pasini D, Bevere M, Alessio G
Nature. 2025; .
PMID: 40074906
DOI: 10.1038/s41586-025-08721-9.
Felsheim B, Fernandez-Martinez A, Fan C, Pfefferle A, Hayward M, Hoadley K
NPJ Breast Cancer. 2025; 11(1):24.
PMID: 40057511
PMC: 11890565.
DOI: 10.1038/s41523-025-00740-z.
Du Y, Gu B, Shi L, She Y, Zhao Q, Gao S
Cancer Med. 2025; 14(5):e70730.
PMID: 40018789
PMC: 11868787.
DOI: 10.1002/cam4.70730.
Ramesh P, Al Kadi A, Borse G, Webendorfer M, Zaun G, Metzenmacher M
Cells. 2025; 14(4).
PMID: 39996719
PMC: 11853756.
DOI: 10.3390/cells14040246.
A pan-cancer analysis of the oncogenic and immunological roles of RGS5 in clear cell renal cell carcinomas based on in vitro experiment validation.
Zhang Y, Wang H, Dai F, He K, Tuo Z, Wang J
Hum Genomics. 2025; 19(1):14.
PMID: 39985100
PMC: 11846387.
DOI: 10.1186/s40246-025-00717-w.
p53-regulated SESN1 and SESN2 regulate cell proliferation and cell death through control of STAT3.
Haidurov A, Zheltukhin A, Snezhkina A, Krasnov G, Kudryavtseva A, Budanov A
Cell Commun Signal. 2025; 23(1):105.
PMID: 39985075
PMC: 11846189.
DOI: 10.1186/s12964-025-02104-3.
An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis.
Yang X, Li Y, Peng Y, Chang Y, He B, Zhang T
Front Immunol. 2025; 16:1546794.
PMID: 39963143
PMC: 11830715.
DOI: 10.3389/fimmu.2025.1546794.
AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer.
Zheng G, Yan Z, Zou J, Zou X, Chai K, Zhang G
Front Oncol. 2025; 15:1520808.
PMID: 39963114
PMC: 11830605.
DOI: 10.3389/fonc.2025.1520808.
Comprehensive pan-cancer analysis of ENOPH1 in human tumors.
Zhang X, Li N, Chu T, Zhao H, Liu T
Discov Oncol. 2025; 16(1):190.
PMID: 39955431
PMC: 11829882.
DOI: 10.1007/s12672-025-01965-x.
Comprehensive dissection of cis-regulatory elements in a 2.8 Mb topologically associated domain in six human cancers.
Caragine C, Le V, Mustafa M, Diaz B, Morris J, Muller S
Nat Commun. 2025; 16(1):1611.
PMID: 39948336
PMC: 11825950.
DOI: 10.1038/s41467-025-56568-5.
Proteogenomic analysis reveals adaptive strategies for alleviating the consequences of aneuploidy in cancer.
Bokenkamp J, Keuper K, Redel S, Barthel K, Johnson L, Becker A
EMBO J. 2025; .
PMID: 39930267
DOI: 10.1038/s44318-025-00372-w.
Comprehensive characterization of micropapillary colorectal adenocarcinoma.
Aijala V, Harkonen J, Mantere T, Elomaa H, Sirnio P, Pohjanen V
J Pathol. 2025; 265(4):408-421.
PMID: 39917902
PMC: 11880967.
DOI: 10.1002/path.6392.
AMEND 2.0: module identification and multi-omic data integration with multiplex-heterogeneous graphs.
Boyd S, Slawson C, Thompson J
BMC Bioinformatics. 2025; 26(1):39.
PMID: 39910456
PMC: 11800622.
DOI: 10.1186/s12859-025-06063-x.
SKI complex loss renders 9p21.3-deleted or MSI-H cancers dependent on PELO.
Borck P, Boyle I, Jankovic K, Bick N, Foster K, Lau A
Nature. 2025; 638(8052):1104-1111.
PMID: 39910293
PMC: 11864980.
DOI: 10.1038/s41586-024-08509-3.
BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies.
Markouli M, Pagoni M, Diamantopoulos P
Front Oncol. 2025; 14:1501950.
PMID: 39906657
PMC: 11790632.
DOI: 10.3389/fonc.2024.1501950.
Understanding metastasis mixed-treatment responses through genomic analyses.
Garcia-Recio S, Zagami P, Felsheim B, Wheless A, Thomas K, Trimarchi R
NPJ Breast Cancer. 2025; 11(1):9.
PMID: 39885167
PMC: 11782668.
DOI: 10.1038/s41523-025-00724-z.
A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer.
Rendo V, Schubert M, Khuu N, Suarez Peredo Rodriguez M, Whyte D, Ling X
Nat Commun. 2025; 16(1):1077.
PMID: 39870664
PMC: 11772776.
DOI: 10.1038/s41467-025-56301-2.
Circle-seq reveals that eccDNA may be a key blood biomarker for HBV-associated liver cancer.
Ran X, Zhao X, Wei Z, Pang H, Tang Y, Liu R
Front Genet. 2025; 15():1454153.
PMID: 39850493
PMC: 11754267.
DOI: 10.3389/fgene.2024.1454153.
The role of Golgi complex proteins in cell division and consequences of their dysregulation.
Iannitti R, Mascanzoni F, Colanzi A, Spano D
Front Cell Dev Biol. 2025; 12():1513472.
PMID: 39839669
PMC: 11747491.
DOI: 10.3389/fcell.2024.1513472.